Reviva Pharmaceuticals Holdings (RVPHW) Financials

RVPHW Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.4 million 13.9 million
2023-06-30 11.8 million 10.2 million
2023-03-31 12.9 million 7.1 million
2022-12-31 18.9 million 6.6 million

RVPHW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.2 million 350410
2023-06-30 -5.3 million 2.6 million
2023-03-31 -8.0 million 51527
2022-12-31 -4.7 million 56586

RVPHW Net Income

No data available :(

RVPHW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.0 million - -
2023-06-30 11.2 million - -
2023-03-31 11.3 million - -
2022-12-31 18.5 million - -

RVPHW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 24.0 million
2023-06-30 22.4 million
2023-03-31 21.8 million
2022-12-31 19.5 million

RVPHW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 8.7 million 2.0 million -
2023-06-30 - 9.0 million 3.1 million -
2023-03-31 - 5.2 million 1.5 million -
2022-12-31 - 6.3 million 1.5 million -

RVPHW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

RVPHW

Price: $0.47

52 week price:
0.47
0.70

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 32413

Market Capitalization: 85.8 million

Links: